These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25086624)

  • 1. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Li C; Xiang X; Zhou Y
    Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
    Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
    Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y; Jiang L; Zhou JY; Zou JJ; Zheng JY; Chen XF; Liu ZM; Shi YQ
    PLoS One; 2013; 8(5):e64851. PubMed ID: 23717668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
    Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.
    Mandegari M; Dastgheib SA; Asadian F; Shaker SH; Tabatabaie SM; Kargar S; Sadeghizadeh-Yazdi J; Neamatzadeh H
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2221-2236. PubMed ID: 34319046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
    Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
    Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
    Zhang H; Liu H; Jiang G
    PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the XRCC1 polymorphisms and thyroid cancer risk: a meta-analysis from case-control studies.
    Wu FF; He XF; Shen HW; Qin GJ
    PLoS One; 2014; 9(9):e87764. PubMed ID: 25211472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z; Hu X; Long J; Su L; Wei B
    Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Arg194Trp, Arg280His and Arg399Gln polymorphisms in X-ray repair cross-complementing group 1 gene and risk of differentiated thyroid carcinoma in Iran.
    Fard-Esfahani P; Fard-Esfahani A; Fayaz S; Ghanbarzadeh B; Saidi P; Mohabati R; Bidoki SK; Majdi M
    Iran Biomed J; 2011; 15(3):73-8. PubMed ID: 21987112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
    Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
    Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of XRCC1 polymorphisms with thyroid cancer risk.
    Wang C; Ai Z
    Tumour Biol; 2014 May; 35(5):4791-7. PubMed ID: 24477575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
    Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
    PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
    Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.